Don't Bite The Hand That Feeds You

[tagthatstock]

imho-traders should be looking at BPAX 2.16 for a massive run soon. one of the best stocks trading under $10 and the target can be ANYTHING a biopharm bloat might want to pay for a developed science that can be 'lobbyied' for human use

could become a monster------very few traders are in it,,,,,and they have other stuff too so they are not a 1 trick pony:


http://finance.yahoo.com/news/BioSante-Pharmaceuticals-bw-15197690.html?.v=4


The cumulative results confirm that:


•BioVant can enhance flu-specific immunity
•BioVant/M1 Protein Flu vaccine protected 100% of the animals from lethal dose of live H1N1 flu virus, the same structure as the current swine flu
•BioVant improves survivability when compared to the vaccine alone with or without other adjuvants
•BioVant may allow for lower doses of flu vaccine thereby increasing the number of doses for a given production of vaccine






confirm its vaccine adjuvant, BioVant™, can increase the efficacy of flu vaccines, including a potential new H1N1 (swine flu) vaccine. Previously presented BioSante data from three BioVant-adjuvanted flu vaccine pre-clinical studies using the M1 protein, H1N1 (similar to today’s swine flu), H3N1 and H5N1 antigens showed that BioVant effectively delivered flu vaccines and concurrently, enhanced the body’s natural immune responses to flu virus antigens, including the potentially pandemic swine flu.